Molecular Attraction
Molecular Attraction is a Swedish bio-attractant company that develops patented, species-specific pheromone and phagostimulant dispensers for low-cost, maintenance-free mosquito control, serving humanitarian organizations, governments, and hospitality buyers.
- Company typePrivate
- Founded2017
- HeadquartersStockholm, Sweden
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What Molecular Attraction does
Molecular Attraction AB is a Swedish bio-attractant discovery company that develops species-specific pheromone-based products to control mosquitoes that transmit dengue, malaria, Zika, and chikungunya. Its platform isolates male aggregation pheromones directly from mosquito swarms and combines them with patented HMBPP phagostimulant compositions to disrupt mating, swarming, and feeding behavior in Anopheles, Aedes, and Culex species without affecting pollinators or other insects. Core products include pheromone blends, phagostimulants, and attractants delivered through NFC-tagged passive dispensers that release for 12 months at 1–2 grams per hectare per day, with no electricity or maintenance required. Field-validated performance includes an 80% mosquito population reduction reported in a 2024 whole-season trial in Dalarna, Sweden.
The company monetizes through hardware sales of pheromone dispensers priced at $0.26 per person protected at full deployment and $0.96 per person during pilots, with pilot deployments structured as multi-year contracts. Go-to-market is a hybrid model: an Early Access Partnership Program for commercial properties (hospitality, leisure, municipal buyers) and humanitarian deployments channeled through UNHCR, beginning with a 2025 pilot covering 143,000 Rohingya refugees in Cox's Bazar at a $137,000 contract value, with a 33-camp rollout to over 1 million people planned for 2027. Customers and trial sites span Sweden, the Seychelles, Spain, Argentina, and Bangladesh. The company is founder-led by Prof. Noushin Emami (Chief Scientific Officer) and chaired by Johan Paleovrachas, with Lech Ignatowicz as CEO, and is backed by Almi Invest, Farvatn Venture, the EIC Accelerator, EQT Foundation, Norrsken, Vinnova, and the European Union, alongside research collaborations with Karolinska Institute and the Liverpool School of Tropical Medicine.
Molecular Attraction firmographics
Firmographics- Name
- Molecular Attraction
- Legal name
- Molecular Attraction AB
- Website
- https://molecular-attraction.com
- Company type
- Private
- Founded year
- 2017
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Molecular Attraction is a Swedish bio-attractant company that develops patented, species-specific pheromone and phagostimulant dispensers for low-cost, maintenance-free mosquito control, serving humanitarian organizations, governments, and hospitality buyers.
- Ownership category
- akta.pro rank
Molecular Attraction industry classification
Industry- Product category
- Pheromone-based mosquito control products
- NAICS
- Pesticide and Other Agricultural Chemical Manufacturing (32532), Exterminating and Pest Control Services (56171), Surface Active Agent Manufacturing (325613), Pesticide and Other Agricultural Chemical Manufacturing (325320)
- SIC
- Agricultural Chemicals (2870), Industrial Organic Chemicals (2860), Miscellaneous Chemical Products (2890)
- akta.pro primary industry
- Integrated Pest Management Products (Pheromones, Attractants, Repellents) (AFABAAAN)
- akta.pro secondary industries
- Mosquito & Tick Control (IMAIAHAI), In2Care/Trap-Based Mosquito Control (Targeted Trapping) (HSAMAEAG), Natural/Green Pest Control Products (CRAJAHAK), Insect & Pest Control (Indoor/Outdoor Insecticides, Repellents, Traps) (CRADAKAJ)
Keywords
Where Molecular Attraction is headquartered
LocationHeadquarters
- HQ city
- Stockholm
- HQ country
- Sweden
- HQ region
- Europe
Offices1 record
Markets served
Molecular Attraction business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Operations, Supply Chain, Marketing or Sales
Revenue model
- Pheromone Dispensers: Sale of patented pheromone dispensers for mosquito control. Products are designed for continuous passive release over 12 months, installed once and running maintenance-free. Pricing at $0.26 per person at full deployment and $0.96 per person during pilot phase.
- Pilot Program Revenue: Revenue from pilot deployments with organizations like UNHCR. The Rohingya refugee camp pilot costs $137,000 total, protecting 143,000 people at $0.96 per person. Full rollout projected at $290,000 for over 1 million people.
- Early Access Partnership Program: Exclusive pre-market access program for properties to receive targeted pheromone control technology before competitors. Limited onboarding for high-touch integration.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Annual | Full deployment pricing: $0.26 per person protected per year |
| Unit Pricing | Multi-year contract | Pilot deployment pricing: $0.96 per person protected per year |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels5 records
Molecular Attraction product offering
Product offeringCore offering
Molecular Attraction develops and sells species-specific pheromone-based mosquito control products, including patented synthetic pheromone blends, HMBPP phagostimulant compositions, and species-specific attractants. The active ingredients are delivered via NFC-tagged pheromone dispensers that release continuously for 12 months at 1–2 grams per hectare per day, designed for installation by non-specialists without electricity or maintenance. The company's products are used by humanitarian organizations, government public health authorities, and leisure/hospitality properties to control Anopheles, Aedes, and Culex mosquitoes.
Product overview
Molecular Attraction develops a portfolio of pheromone-based mosquito control products including patented pheromone blends (Mosquito Aggregation Pheromone, Patent WO2019197681A1), phagostimulant compositions (HMBPP Phagostimulant, Patent WO2023057483A1), and attractants. These are delivered via NFC-tagged pheromone dispensers that provide 12 months of continuous, passive release. The products target Anopheles, Aedes, and Culex mosquito species through species-specific chemical blends that disrupt mating, swarming, and reproduction. The portfolio includes the Early Access Partnership Program for pre-market integration and the Refugee Response Program for humanitarian deployments with UNHCR. Applications span urban environments, leisure/hospitality settings (hotels, golf courses), and disaster relief operations.
Differentiator
Problem solved
Functional benefit
Products and services
- Ph Pheromones Patented mosquito-specific pheromone blends that disrupt mating, swarming, and reproduction by exploiting mosquitoes' own olfactory communication systems, targeting Anopheles, Aedes, and Culex species without affecting other insects. Used by public health authorities, humanitarian organizations, and hospitality customers for vector control.
- Phagostimulants Patented chemical blends based on HMBPP (E-4-hydroxy-3-methyl-but-2-enyl pyrophosphate) that stimulate mosquito feeding behavior and can be used in conjunction with pheromones to enhance mosquito control. Used in vector control programs targeting Anopheles, Aedes, and Culex mosquitoes.
- Attractants Species-specific volatile compound blends that lure mosquitoes by mimicking natural pheromones and feeding cues, used for population surveillance and control of Anopheles, Aedes, and Culex mosquitoes.
- Pheromone Dispensers NFC-tagged dispensers that provide continuous, passive release of the company's patented pheromone blends for 12 months at 1–2 grams per hectare per day, designed for installation by non-specialists on 50m x 50m grids without electricity or maintenance. Used by humanitarian organizations, government public health authorities, and hospitality customers for area-wide mosquito control.
- Early Access Partnership Program Pre-market access program providing targeted pheromone control technology to a strictly limited number of hospitality and enterprise properties for field trials, usability testing, and community engagement ahead of general availability. Customers include hotels, resorts, golf courses, and other leisure venues.
- Refugee Response Program Pilot initiative with UNHCR deploying pheromone dispensers in refugee camps to protect populations from mosquito-borne diseases including dengue, malaria, and chikungunya without traditional insecticides, electricity, or maintenance. Initial deployment covers 10% of the Rohingya refugee camps before monsoon season, with full rollout planned for 2027.
Quantifiable outcome
- 80% mosquito population reduction in field trials (2024, Dalarna Region Sweden)
- +5 more outcomes
Companies that use Molecular Attraction
Customer profileNamed customers5 records
Segments4 records
Ideal customer profiles3 records
Molecular Attraction technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
Molecular Attraction partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core.
- UNHCRcoreStrategic partnership with UNHCR to deploy pheromone dispensers in Rohingya refugee camps in Cox's Bazar, Bangladesh. Pilot targets 10% of camps (143,000 people) at $0.96/person/year before monsoon season. Full rollout planned for 2027 to protect over 1 million people. Local staff recruited from among refugees. All permits secured from RRRC.
- Karolinska InstitutecoreResearch collaboration with laboratories of founder Professor Noushin Emami. The partnership supports multidisciplinary research at the intersection of vector biology, olfactory signalling, and pathogen transmission. Central to developing next-generation, species-specific mosquito control solutions.
- Liverpool School of Tropical MedicinecoreResearch collaboration with laboratories of founder Professor Noushin Emami. Joint research efforts support multidisciplinary team working at intersection of vector biology, olfactory signalling, and pathogen transmission.
Scale indicators10 records
Recent moves6 records
Expansion highlights6 records
Molecular Attraction competitors and assessment
Company assessmentDirect peers
- Oxitec: Oxitec develops and releases genetically modified mosquitoes (Friendly™ mosquitoes) for Aedes population suppression. It is the closest direct competitor to Molecular Attraction in species-specific, non-insecticidal vector control targeting the same Anopheles/Aedes/Culex disease vectors.
- In2Care: In2Care produces auto-dissemination trap stations that use pyriproxyfen and biological larvicides to control Aedes and other container-breeding mosquitoes. It is a direct competitor in targeted, trap-based mosquito control deployed by municipalities and public health authorities.
- Biogents: Biogents manufactures mosquito traps using patented lure blends (BG-Sweetscent, BG-Lure) that combine artificial host and sugar cues. It competes with Molecular Attraction in species-specific attractant-based surveillance and population reduction.
- Suterra: Suterra (a BASF subsidiary) is one of the world's leading pheromone-based pest control companies for agricultural pests such as codling moth and grapevine moth. It is the closest analog in pheromone-based pest control commercialization, even though it operates in agricultural rather than public-health mosquito control.
Emerging players
- ISCA Technologies: ISCA Technologies develops semiochemical and pheromone-based solutions for pest management across agriculture and vector control, including SPLAT and NOCTOS formulations. It overlaps with Molecular Attraction in species-specific pheromone R&D and formulation.
- Vestaron: Vestaron develops peptide-based biopesticides targeting insect pests with novel modes of action to address resistance. It competes in the broader sustainable, non-chemical pest control category where Molecular Attraction also plays.
Broad incumbents
- Anticimex: Anticimex is one of the largest global pest control service operators, offering mosquito, rodent, and general pest management to residential and commercial customers. It is both a financial investor in Molecular Attraction and a potential distribution partner for pheromone technology at scale.
- Rentokil Initial: Rentokil Initial is the world's largest commercial pest control services provider, operating across 80+ countries. It overlaps with Molecular Attraction in mosquito and vector control services, particularly for municipal and commercial accounts.
- Sumitomo Chemical: Sumitomo Chemical is a global manufacturer of vector control products including Olyset long-lasting insecticidal nets and SumiShield. It competes in mosquito-borne disease control across humanitarian and government channels where Molecular Attraction also sells.
- SC Johnson (OFF! and Raid): SC Johnson markets OFF!, Raid, and Autan consumer mosquito repellent and insecticide brands globally. It represents the incumbent consumer/lifestyle segment that Molecular Attraction's hospitality/leisure GTM motion must compete against for mindshare and shelf space.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Molecular Attraction social profiles
Digital presenceMolecular Attraction financial estimates
Financial estimateRevenue estimate
Valuation estimate
Molecular Attraction leadership team
Management profileNumber of profiles
Profiles7 records
Molecular Attraction funding detail
Funding detailFunding overview
Funding rounds4 records
Investors4 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Molecular Attraction M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Molecular Attraction
What does Molecular Attraction do?
Molecular Attraction develops and sells species-specific pheromone-based mosquito control products, including patented synthetic pheromone blends, HMBPP phagostimulant compositions, and species-specific attractants. The active ingredients are delivered via NFC-tagged pheromone dispensers that release continuously for 12 months at 1–2 grams per hectare per day, designed for installation by non-specialists without electricity or maintenance. The company's products are used by humanitarian organizations, government public health authorities, and leisure/hospitality properties to control Anopheles, Aedes, and Culex mosquitoes.
Is Molecular Attraction a public or private company?
Molecular Attraction is a private company. It is classified as venture growth investor backed and is currently operating.
When was Molecular Attraction founded?
Molecular Attraction was founded in 2017. It employs 1 to 10 people.
Where is Molecular Attraction based?
Molecular Attraction is headquartered in Stockholm, Sweden, in the Europe region.
How does Molecular Attraction make money?
Three revenue lines are on record. Pheromone Dispensers are the primary driver. The others are pilot Program Revenue and early Access Partnership Program.
Who are Molecular Attraction's main competitors?
Direct peers on record are Oxitec, In2Care, Biogents and Suterra. Emerging players are ISCA Technologies and Vestaron. Broad incumbents are Anticimex, Rentokil Initial, Sumitomo Chemical and SC Johnson (OFF! and Raid).
Does Molecular Attraction have an API?
No public API is recorded for Molecular Attraction.
What industry is Molecular Attraction in?
Molecular Attraction's product category is Pheromone-based mosquito control products. Its primary akta.pro industry code is AFABAAAN, Integrated Pest Management Products (Pheromones, Attractants, Repellents), with a secondary code of IMAIAHAI, Mosquito & Tick Control. Its NAICS code is 32532 and its SIC code is 2870.